AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
RELATIONSHIP BETWEEN DIDANOSINE EXPOSURE AND SURROGATE MARKER RESPONSE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED OUTPATIENTS
Authors: ADAMS JM SHELTON MJ HEWITT RG GRASELA TH DEREMER M MORSE GD
Citation: Jm. Adams et al., RELATIONSHIP BETWEEN DIDANOSINE EXPOSURE AND SURROGATE MARKER RESPONSE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED OUTPATIENTS, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 821-826
ZALCITABINE POPULATION PHARMACOKINETICS - APPLICATION OF RADIOIMMUNOASSAY
Authors: ADAMS JM SHELTON MJ HEWITT RG DEREMER M DIFRANCESCO R GRASELA TH MORSE GD
Citation: Jm. Adams et al., ZALCITABINE POPULATION PHARMACOKINETICS - APPLICATION OF RADIOIMMUNOASSAY, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 409-413
PROSPECTIVE USE OF POPULATION PHARMACOKINETICS PHARMACODYNAMICS IN THE DEVELOPMENT OF CISATRACURIUM/
Authors: SCHMIT VD FIEDLERKELLY J PHILLIPS L GRASELA TH
Citation: Vd. Schmit et al., PROSPECTIVE USE OF POPULATION PHARMACOKINETICS PHARMACODYNAMICS IN THE DEVELOPMENT OF CISATRACURIUM/, Pharmaceutical research, 14(1), 1997, pp. 91-97
POPULATION PHARMACOKINETICS OF ADD-ON LAMOTRIGINE IN PEDIATRIC-PATIENTS
Authors: CHEN C GRASELA TH PHILLIPS L FIEDLERKELLY JB WOMBLE GP RISNER ME YAU MK
Citation: C. Chen et al., POPULATION PHARMACOKINETICS OF ADD-ON LAMOTRIGINE IN PEDIATRIC-PATIENTS, Annals of neurology, 42(3), 1997, pp. 32-32
SYMPTOMATIC CARDIOTOXICITY ASSOCIATED WITH 5-FLUOROURACIL
Authors: MEYER CC CALIS KA BURKE LB WALAWANDER CA GRASELA TH
Citation: Cc. Meyer et al., SYMPTOMATIC CARDIOTOXICITY ASSOCIATED WITH 5-FLUOROURACIL, Pharmacotherapy, 17(4), 1997, pp. 729-736
DOSE PROPORTIONALITY OF CISATRACURIUM
Authors: SCHMITH VD FIEDLERKELLY J PHILLIPS L GRASELA TH
Citation: Vd. Schmith et al., DOSE PROPORTIONALITY OF CISATRACURIUM, Journal of clinical pharmacology, 37(7), 1997, pp. 625-629
THE POPULATION PHARMACOKINETICS OF PRAMIPEXOLE IN PARKINSONSS DISEASEPATIENTS
Authors: WRIGHT CE GRASELA TH PHILLIPS L
Citation: Ce. Wright et al., THE POPULATION PHARMACOKINETICS OF PRAMIPEXOLE IN PARKINSONSS DISEASEPATIENTS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 70-70
BYPASSING THE PACU - A NEW PARADIGM IN AMBULATORY SURGERY
Authors: APFELBAUM JL GRASELA TH WALAWANDER CA BARASH P BARTON C KAPUR P KOPMAN A KORTTILA K MCLESKEY C PALMER J ROIZEN M SHAUGHNESSY R WATKINS D WETCHLER B PALLAIS S
Citation: Jl. Apfelbaum et al., BYPASSING THE PACU - A NEW PARADIGM IN AMBULATORY SURGERY, Anesthesiology, 87(3), 1997, pp. 32-32
BENCHMARKING DATA TO MODIFY PRACTICE REDUCES AMBULATORY SURGICAL CENTER EXPENSES
Authors: APFELBAUM JL GRASELA TH WALAWANDER CA BARASH P BARTON C KAPUR P KOPMAN A KORTTILA K MCLESKEY C PALMER J ROIZEN M SHAUGHNESSY R WATKINS D WETCHLER B PALLAIS S
Citation: Jl. Apfelbaum et al., BENCHMARKING DATA TO MODIFY PRACTICE REDUCES AMBULATORY SURGICAL CENTER EXPENSES, Anesthesiology, 87(3), 1997, pp. 963-963
PHARMACOEPIDEMIOLOGY - A SCIENTIFIC BASIS FOR OUTCOMES RESEARCH
Authors: GRASELA TH
Citation: Th. Grasela, PHARMACOEPIDEMIOLOGY - A SCIENTIFIC BASIS FOR OUTCOMES RESEARCH, The Annals of pharmacotherapy, 30(2), 1996, pp. 188-190
ADVERSE DRUG REACTION REPORTING IN A MULTICENTER SURVEILLANCE STUDY
Authors: TIMM EG WELAGE LS WALAWANDER CA SAYERS JFB KARPIUK EL DAVIS TD GRASELA TH
Citation: Eg. Timm et al., ADVERSE DRUG REACTION REPORTING IN A MULTICENTER SURVEILLANCE STUDY, The Annals of pharmacotherapy, 29(3), 1995, pp. 240-245
PRETREATMENT REGIMENS FOR ADVERSE EVENTS RELATED TO INFUSION OF AMPHOTERICIN-B
Authors: GOODWIN SD CLEARY JD WALAWANDER CA TAYLOR JW GRASELA TH
Citation: Sd. Goodwin et al., PRETREATMENT REGIMENS FOR ADVERSE EVENTS RELATED TO INFUSION OF AMPHOTERICIN-B, Clinical infectious diseases, 20(4), 1995, pp. 755-761
SEPSIS SYNDROME AND ASSOCIATED SEQUELAE IN PATIENTS AT HIGH-RISK FOR GRAM-NEGATIVE SEPSIS
Authors: CONBOY K WELAGE LS WALAWANDER CA DUFFY LC WELLIVER RC ZIELEZNY MA DIPIRO JT RAEBEL MA GRASELA TH
Citation: K. Conboy et al., SEPSIS SYNDROME AND ASSOCIATED SEQUELAE IN PATIENTS AT HIGH-RISK FOR GRAM-NEGATIVE SEPSIS, Pharmacotherapy, 15(1), 1995, pp. 66-77
POPULATION PHARMACOKINETICS PHARMACODYNAMICS (PWPD) OF 51W89 IN HEALTHY PEDIATRIC-PATIENTS
Authors: PHILLIPS L SCHMITH VD BRANDOM BW FIEDLERKELLY J GRASELA TH
Citation: L. Phillips et al., POPULATION PHARMACOKINETICS PHARMACODYNAMICS (PWPD) OF 51W89 IN HEALTHY PEDIATRIC-PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 213-213
POPULATION PHARMACOKINETICS PHARMACODYNAMICS (PW PD) OF 51W89, A NEW NEUROMUSCULAR BLOCKING-AGENT/
Authors: SCHMITH VD FIEDLERKELLY J PHILLIPS L GRASELA TH
Citation: Vd. Schmith et al., POPULATION PHARMACOKINETICS PHARMACODYNAMICS (PW PD) OF 51W89, A NEW NEUROMUSCULAR BLOCKING-AGENT/, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 213-213
THE PUBLICATION OF COMMERCIALLY SUPPORTED SUPPLEMENTS STATEMENT - RESPONSE
Authors: APFELBAUM JL GRASELA TH HUG CC MCLESKEY CH NAHRWOLD ML STANLEY TH THISTED RA WALAWANDER CA WHITE PF
Citation: Jl. Apfelbaum et al., THE PUBLICATION OF COMMERCIALLY SUPPORTED SUPPLEMENTS STATEMENT - RESPONSE, Anesthesia and analgesia, 81(4), 1995, pp. 888-889
ALTERNATIVES TO INTRAVENOUS TETRACYCLINE HYDROCHLORIDE FOR MALIGNANT PLEURAL EFFUSIONS
Authors: GRASELA TH WALAWANDER CA JOLSON HM KENNEDY DL
Citation: Th. Grasela et al., ALTERNATIVES TO INTRAVENOUS TETRACYCLINE HYDROCHLORIDE FOR MALIGNANT PLEURAL EFFUSIONS, The Annals of pharmacotherapy, 28(7-8), 1994, pp. 968-969
RISK-FACTORS FOR ACUTE RENAL-INSUFFICIENCY IN PATIENTS WITH SUSPECTEDOR DOCUMENTED BACTERIAL PNEUMONIA
Authors: WELAGE LS WALAWANDER CA TIMM EG GRASELA TH
Citation: Ls. Welage et al., RISK-FACTORS FOR ACUTE RENAL-INSUFFICIENCY IN PATIENTS WITH SUSPECTEDOR DOCUMENTED BACTERIAL PNEUMONIA, The Annals of pharmacotherapy, 28(4), 1994, pp. 515-522
USE OF ANTIFUNGAL THERAPY IN HOSPITALIZED-PATIENTS .1. RESULTS PRIOR TO THE MARKETING OF FLUCONAZOLE
Authors: GRASELA TH GOODWIN SD PASKO MT WALAWANDER CA RAEBEL MA
Citation: Th. Grasela et al., USE OF ANTIFUNGAL THERAPY IN HOSPITALIZED-PATIENTS .1. RESULTS PRIOR TO THE MARKETING OF FLUCONAZOLE, The Annals of pharmacotherapy, 28(2), 1994, pp. 252-260
USE OF ANTIFUNGAL THERAPY IN HOSPITALIZED-PATIENTS .2. RESULTS AFTER THE MARKETING OF FLUCONAZOLE
Authors: GRASELA TH PASKO MT GOODWIN SD WALAWANDER CA BLACKWELDER N BRUDERHOLT RJ
Citation: Th. Grasela et al., USE OF ANTIFUNGAL THERAPY IN HOSPITALIZED-PATIENTS .2. RESULTS AFTER THE MARKETING OF FLUCONAZOLE, The Annals of pharmacotherapy, 28(2), 1994, pp. 261-270
ANALYSIS OF POTENTIAL RISK-FACTORS ASSOCIATED WITH THE DEVELOPMENT OFPANCREATITIS IN PHASE-I PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX RECEIVING DIDANOSINE
Authors: GRASELA TH WALAWANDER CA BELTANGADY M KNUPP CA MARTIN RR DUNKLE LM BARBHAIYA RH PITTMAN KA DOLIN R VALENTINE FT LIEBMAN HA
Citation: Th. Grasela et al., ANALYSIS OF POTENTIAL RISK-FACTORS ASSOCIATED WITH THE DEVELOPMENT OFPANCREATITIS IN PHASE-I PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX RECEIVING DIDANOSINE, The Journal of infectious diseases, 169(6), 1994, pp. 1250-1255
EFFECT OF ADVANCED AGE ON THE PHARMACODYNAMICS OF DOXACURIUM - REPLY
Authors: SCHMITH VD FIEDLERKELLY J GRASELA TH
Citation: Vd. Schmith et al., EFFECT OF ADVANCED AGE ON THE PHARMACODYNAMICS OF DOXACURIUM - REPLY, Clinical pharmacology and therapeutics, 55(3), 1994, pp. 360-362
LAMOTRIGINE PHARMACODYNAMICS IN ADULT PATIENTS - SAFETY AND EFFICACY
Authors: YAU MK LAI AA WOMBLE GP WARGIN WA GRASELA TH FIEDLERKELLY JB
Citation: Mk. Yau et al., LAMOTRIGINE PHARMACODYNAMICS IN ADULT PATIENTS - SAFETY AND EFFICACY, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 160-160
THE CLINICAL-EVALUATION OF NEW DRUGS FOR SEPSIS - A PROSPECTIVE-STUDYDESIGN BASED ON SURVIVAL ANALYSIS
Authors: KNAUS WA HARRELL FE FISHER CJ WAGNER DP OPAL SM SADOFF JC DRAPER EA WALAWANDER CA CONBOY K GRASELA TH
Citation: Wa. Knaus et al., THE CLINICAL-EVALUATION OF NEW DRUGS FOR SEPSIS - A PROSPECTIVE-STUDYDESIGN BASED ON SURVIVAL ANALYSIS, JAMA, the journal of the American Medical Association, 270(10), 1993, pp. 1233-1241
PREDICTIVE PERFORMANCE OF POPULATION PHARMACOKINETIC PARAMETERS OF TIANEPTINE AS APPLIED TO PLASMA-CONCENTRATIONS FROM A POSTMARKETING STUDY
Authors: GRASELA TH FIEDLERKELLY IB SALVADORI C MAREY C JOCHEMSEN R LOO H
Citation: Th. Grasela et al., PREDICTIVE PERFORMANCE OF POPULATION PHARMACOKINETIC PARAMETERS OF TIANEPTINE AS APPLIED TO PLASMA-CONCENTRATIONS FROM A POSTMARKETING STUDY, European Journal of Clinical Pharmacology, 45(2), 1993, pp. 123-128
Risultati: 1-25 | 26-36